PCR-based detection and eradication of mycoplasmal infections from various mammalian cell lines: a local experience |
| |
Authors: | Vahid Molla Kazemiha Mohammad Ali Shokrgozar Mohammad Reza Arabestani Morteza Shojaei Moghadam Shahram Azari Susan Maleki Amir Amanzadeh Mahmood Jeddi Tehrani Fazel Shokri |
| |
Affiliation: | (1) National Cell Bank of Iran, Pasteur Institute of Iran, Tehran, Iran;(2) Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia;(3) Department of Biology, School of Science, Shahid Chamran University, Ahvaz, Iran;(4) Monoclonal Antibody Research Center, Avicenna Research Institute, Tehran, Iran;(5) Immune and Gene Therapy Laboratory, Cancer Center Karolinska, Karolinska Institute, Stockholm, Sweden;(6) Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; |
| |
Abstract: | A total of 200 cell lines including different human, monkey, mice, hamster and rat cell types were examined for mycoplasma infection status. PCR assay using generic-specific universal primers showed that 40 (20%) of the cell lines are contaminated with mycoplasma. Employment of species-specific primers within these infected cell lines revealed infection with M. hyorhinis (42.5%), M. fermentas (37.5%), M. arginini (37.5%), M. orale (12.5%) and A. laidlawii (7.5%). A number of the cultures were coinfected with 2 or 3 different species. Contaminated samples were treated with BM-Cyclin, Ciprofloxacin and mycoplasma removal agent (MRA). Mycoplasma eradication was subsequently checked by PCR following 2 weeks continuous culture of treated cells in antibiotic free culture medium. Mycoplasmal infections were eradicated in 100, 70 and 42% of infected cell lines when the samples were treated with BM-Cyclin, MRA and Ciprofloxacin, respectively. However, 12% (BM-Cyclin), 62.5% (MRA) and 82.5% (Ciprofloxacin) of mycoplasma regrowth was observed 4 months after the treatment. Notably, the risk of spontaneous culture death was 17.5, 12.5 and 0% for BM-Cyclin, MRA and Ciprofloxacin, respectively. |
| |
Keywords: | Mycoplasmal infection Mammalian cell lines Elimination Antibiotics PCR-based detection |
本文献已被 SpringerLink 等数据库收录! |
|